Desitin Pharma Limited, also known as Desitin Arzneimittel GmbH, is a renowned international brand that operates in Germany, Switzerland, Scandinavia, and Eastern Europe. With a focus on the treatment of neurological and psychiatric illnesses, Desitin offers a wide range of sophisticated products for conditions like epilepsy and Parkinson's syndrome. As pioneers in pharmacotherapy optimization, Desitin collaborates with other innovative companies to develop cutting-edge treatments for diseases of the central nervous system.

The company takes pride in its role as a trusted partner for physicians, pharmacists, patients, and their families, providing comprehensive product support and expert assistance. Desitin also advocates for individuals suffering from epilepsy and Parkinson's, engaging in dialogue with healthcare providers and policymakers to address their unique needs. With an extensive portfolio of WHO-recommended therapeutics for epilepsy and Parkinson's disease, Desitin is committed to improving long-term treatment success and enhancing the overall quality of life for those affected